China Shenghuo Pharmaceutical Holdings Inc
DelistedCIK 1335106fmd_1ANJ681THRNHVCK0WQD1F1GWVZManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2012, 8 periods
Loading
Latest annual · FY2011
Millions- Total revenues
- 44
- Gross profit
- 27
- Operating income
- 2
- Net income
- 0
- Free cash flow
- (3)
Latest quarter · Q1 FY2012
Millions- Free cash flow
- 0
China Shenghuo Pharmaceutical Holdings Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2011 | FY2010 | Change | Source |
|---|---|---|---|---|
| Revenue | $44.2 million | $32.7 million | +35.1% | 10-K 2012-03-30 · proof |
| Gross profit | $27.2 million | $21.5 million | +26.4% | 10-K 2012-03-30 · proof |
| Operating income | $1.6 million | $1.5 million | +8.4% | 10-K 2012-03-30 · proof |
| Net income | $149,680 | $1.2 million | -87.7% | 10-K 2012-03-30 · proof |
| Cash from operating activities | -$970,409 | $5.8 million | -116.6% | 10-K 2012-03-30 · proof |
| Free cash flow | -$3.3 million | -$2.5 million | 10-K 2012-03-30 · proof | |
| Total assets | $58.3 million | $45.3 million | +28.6% | 10-K 2012-03-30 · proof |
| Total liabilities | $52.8 million | $43.3 million | +21.9% | 10-K 2012-03-30 · proof |
| Cash and cash equivalents | $1.2 million | $1.7 million | -25.3% | 10-K 2012-03-30 · proof |
- What was China Shenghuo Pharmaceutical Holdings Inc's revenue in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported revenue of $44.2 million for fiscal 2011 (the year ended Dec 31, 2011), against $32.7 million the year before (+35.1%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was China Shenghuo Pharmaceutical Holdings Inc's gross profit in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported gross profit of $27.2 million for fiscal 2011 (the year ended Dec 31, 2011), against $21.5 million the year before (+26.4%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was China Shenghuo Pharmaceutical Holdings Inc's operating income in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported operating income of $1.6 million for fiscal 2011 (the year ended Dec 31, 2011), against $1.5 million the year before (+8.4%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was China Shenghuo Pharmaceutical Holdings Inc's net income in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported net income of $149,680 for fiscal 2011 (the year ended Dec 31, 2011), against $1.2 million the year before (-87.7%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was China Shenghuo Pharmaceutical Holdings Inc's cash from operating activities in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported cash from operating activities of -$970,409 for fiscal 2011 (the year ended Dec 31, 2011), against $5.8 million the year before (-116.6%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What was China Shenghuo Pharmaceutical Holdings Inc's free cash flow in fiscal 2011?
- China Shenghuo Pharmaceutical Holdings Inc reported free cash flow of -$3.3 million for fiscal 2011 (the year ended Dec 31, 2011), against -$2.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are China Shenghuo Pharmaceutical Holdings Inc's total assets?
- As of Dec 31, 2011, China Shenghuo Pharmaceutical Holdings Inc reported total assets of $58.3 million, against $45.3 million a year earlier (+28.6%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are China Shenghuo Pharmaceutical Holdings Inc's total liabilities?
- As of Dec 31, 2011, China Shenghuo Pharmaceutical Holdings Inc reported total liabilities of $52.8 million, against $43.3 million a year earlier (+21.9%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
- What are China Shenghuo Pharmaceutical Holdings Inc's cash and cash equivalents?
- As of Dec 31, 2011, China Shenghuo Pharmaceutical Holdings Inc reported cash and cash equivalents of $1.2 million, against $1.7 million a year earlier (-25.3%). Source: the 10-K filed with the SEC on Mar 30, 2012. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1335106&period_type=annual&limit=5"Information only, not investment advice.